Full text is available at the source.
Abstract
Feeding-fasting cycles may govern colorectal cancer sensitivity to PPAR antagonists, rather than tumor-intrinsic clocks.
- Bmal1 oscillations and daily variation in drug sensitivity were observed in colorectal cancer cells in standard high-glucose, low-fat conditions.
- Nutrient-defined media that mimic feeding and fasting eliminated time-dependent variability in drug responses across different models.
- The fed state increased sensitivity of spheroids and patient-derived organoids to PPAR-γ antagonism.
- Administering PPAR-γ antagonists to mice in the fed state resulted in prolonged survival and reduced liver toxicity.
- Bmal-1-silenced colorectal cancer cells confirmed that feeding-fasting rhythms influence sensitivity to PPAR antagonists.
- Nutrient-alternating 3D tumor models may enhance the evaluation of metabolism-targeted anticancer treatments.
Simplified